Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L J Dearling

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 1, 2007
Technological advances in radioimmunotherapyJ L J Dearling, R B Pedley
British Journal of Cancer|August 7, 2008
Fractionated 131I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in miceJ A Violet, J L J Dearling, A J Green, et al.
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
British Journal of Cancer|May 24, 2007
Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour modelsE El-Emir, J L J Dearling, A Huhalov, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 1, 2007
Technological advances in radioimmunotherapyJ L J Dearling, R B Pedley
British Journal of Cancer|August 7, 2008
Fractionated 131I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in miceJ A Violet, J L J Dearling, A J Green, et al.
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
British Journal of Cancer|May 24, 2007
Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour modelsE El-Emir, J L J Dearling, A Huhalov, et al.
Pageof 1